Business Description
Level Biotechnology Inc
NAICS : 325412
SIC : 2834
ISIN : TW0003118006
Description
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 28.21 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.03 | |||||
| Debt-to-EBITDA | 0.13 | |||||
| Interest Coverage | 239.07 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.34 | |||||
| Beneish M-Score | -1.93 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -0.6 | |||||
| 3-Year EBITDA Growth Rate | 1.7 | |||||
| 3-Year EPS without NRI Growth Rate | 2.8 | |||||
| 3-Year FCF Growth Rate | -8.2 | |||||
| 3-Year Book Growth Rate | 1.2 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.98 | |||||
| 9-Day RSI | 52.63 | |||||
| 14-Day RSI | 50.72 | |||||
| 6-1 Month Momentum % | -5.06 | |||||
| 12-1 Month Momentum % | 4.42 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | |||||
| Quick Ratio | 2.23 | |||||
| Cash Ratio | 1.62 | |||||
| Days Inventory | 70.49 | |||||
| Days Sales Outstanding | 64.17 | |||||
| Days Payable | 39.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 5.28 | |||||
| Dividend Payout Ratio | 0.84 | |||||
| 3-Year Dividend Growth Rate | 9.4 | |||||
| Forward Dividend Yield % | 5.28 | |||||
| 5-Year Yield-on-Cost % | 6.61 | |||||
| Shareholder Yield % | 5.15 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 32.81 | |||||
| Operating Margin % | 10.38 | |||||
| Net Margin % | 9.14 | |||||
| FCF Margin % | 7.31 | |||||
| ROE % | 12.06 | |||||
| ROA % | 8.01 | |||||
| ROIC % | 20.15 | |||||
| ROC (Joel Greenblatt) % | 78.15 | |||||
| ROCE % | 14.64 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 15.95 | |||||
| PE Ratio without NRI | 15.91 | |||||
| Shiller PE Ratio | 14.08 | |||||
| Price-to-Owner-Earnings | 20.54 | |||||
| PEG Ratio | 2.09 | |||||
| PS Ratio | 1.46 | |||||
| PB Ratio | 1.95 | |||||
| Price-to-Tangible-Book | 1.94 | |||||
| Price-to-Free-Cash-Flow | 20.12 | |||||
| Price-to-Operating-Cash-Flow | 18.84 | |||||
| EV-to-EBIT | 8.14 | |||||
| EV-to-EBITDA | 6.47 | |||||
| EV-to-Revenue | 0.93 | |||||
| EV-to-FCF | 12.7 | |||||
| Price-to-Projected-FCF | 0.87 | |||||
| Price-to-Median-PS-Value | 0.92 | |||||
| Price-to-Graham-Number | 1.17 | |||||
| Price-to-Net-Current-Asset-Value | 2.75 | |||||
| Price-to-Net-Cash | 7.89 | |||||
| Earnings Yield (Greenblatt) % | 12.29 | |||||
| FCF Yield % | 5.01 | |||||
| Forward Rate of Return (Yacktman) % | 11.81 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 716.086 | ||
| EPS (TTM) (NT$) | 2.02 | ||
| Beta | 0.36 | ||
| Volatility % | 14.88 | ||
| 14-Day RSI | 50.72 | ||
| 14-Day ATR (NT$) | 0.271335 | ||
| 20-Day SMA (NT$) | 32.1425 | ||
| 12-1 Month Momentum % | 4.42 | ||
| 52-Week Range (NT$) | 29.6 - 39.9 | ||
| Shares Outstanding (Mil) | 32.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Level Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Level Biotechnology Inc Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Level Biotechnology Inc Frequently Asked Questions
What is Level Biotechnology Inc(ROCO:3118)'s stock price today?
The current price of ROCO:3118 is NT$32.20. The 52 week high of ROCO:3118 is NT$39.90 and 52 week low is NT$29.60.
When is next earnings date of Level Biotechnology Inc(ROCO:3118)?
The next earnings date of Level Biotechnology Inc(ROCO:3118) is .
Does Level Biotechnology Inc(ROCO:3118) pay dividends? If so, how much?
The Dividend Yield %  of Level Biotechnology Inc(ROCO:3118) is 5.28% (As of Today), Highest Dividend Payout Ratio of Level Biotechnology Inc(ROCO:3118) was 1.5. The lowest was 0.69. And the median was 0.85. The  Forward Dividend Yield % of Level Biotechnology Inc(ROCO:3118) is 5.28%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers